完整ACTH的LC-MS/MS检测作为免疫分析结果临床不一致时的仲裁方法
本研究开发了一种选择性检测生物活性完整ACTH(iACTH)的LC-MS/MS方法,并用于解决两种免疫分析(Roche Elecsys与Siemens Immulite)结果不一致的问题。结果表明,在结果不一致的样本中,仅Roche结果与iACTH浓度高度正相关,该LC-MS/MS方法可作为临床不一致结果的仲裁。
要点
- iACTH LC-MS/MS可选择性检测完整ACTH及活性片段。
- 在免疫分析结果不一致时,Roche结果与iACTH高度正相关。
- 该方法可用于仲裁临床不一致的ACTH免疫分析结果。
核心结论
- 免疫沉淀生物活性ACTH后行LC-MS/MS分析可选择性检测血浆iACTH及活性片段,并仲裁临床不一致结果。
研究设计与样本
- 开发多反应监测LC-MS/MS方法选择性检测完整iACTH及类似物/片段(ACTH1-24和ACTH18-39)。
- 用MALDI-TOF质谱进行Roche Elecsys抗体表位定位,并比较Roche Elecsys与Siemens Immulite ACTH免疫分析。
- 在部分样本中用LC-MS/MS测定iACTH浓度。
主要发现
- iACTH LC-MS/MS检测下限为9 pg/mL(2 pmol/L),线性范围9至1938 pg/mL(2至427 pmol/L)。
- Roche捕获抗体结合ACTH残基9-12,检测抗体结合残基36-39。
- 对于两种免疫分析结果不一致的样本,仅Roche结果与iACTH浓度高度正相关。
关键数值与推荐
- iACTH LC-MS/MS检测下限9 pg/mL(2 pmol/L),线性范围9-1938 pg/mL(2-427 pmol/L)。
- Roche捕获抗体结合ACTH残基9-12,检测抗体结合残基36-39。
- 不一致样本中仅Roche结果与iACTH浓度高度正相关。
临床怎么用
- 当ACTH免疫分析结果临床不一致时,可用iACTH LC-MS/MS方法仲裁iACTH浓度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Measurement of plasma adrenocorticotropic hormone (ACTH) is key in the differential diagnosis of hypothalamic-pituitary-adrenal disorders. Two-site sandwich immunoassays dominate clinical testing of ACTH in North America; however, discordant results between manufacturers have been repeatedly reported. To resolve the discrepancy, we developed a liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for the intended measurand, biologically active intact ACTH (iACTH). METHODS: The multiple reaction monitoring LC-MS/MS assay was designed to selectively measure full-length iACTH, as well as ACTH analogs and fragments (i.e., ACTH1-24 and ACTH18-39). Epitope assignment of the Roche Elecsys antibodies was performed by MALDI-TOF mass spectrometry. A method comparison between Roche Elecsys and Siemens Immulite ACTH immunoassays was performed and clinically concordant/discordant results identified. In a subset of these samples, the iACTH concentration was determined using the LC-MS/MS method. RESULTS: The lower limit of the measuring interval of the iACTH LC-MS/MS assay was 9 pg/mL (2 pmol/L). The assay was linear from 9 to 1938 pg/mL (2 to 427 pmol/L). Epitope mapping revealed that the Roche capture and detection antibodies bound residues 9-12 and 36-39 of ACTH, respectively. The iACTH LC-MS/MS analysis demonstrated that for discordant results between 2 immunoassays studied, only the Roche results were highly positively correlated with the iACTH concentration. CONCLUSIONS: Immunoprecipitation of biologically active ACTH molecules followed by LC-MS/MS analysis enabled selective detection of iACTH and relevant biologically active fragments in plasma. Applied to the investigation of clinically discrepant results, this method can act as an arbiter of the concentration of iACTH present.
引用
- Shi J, Dhaliwal P, Zi Zheng Y, et al. An Intact ACTH LC-MS/MS Assay as an Arbiter of Clinically Discordant Immunoassay Results. Clin Chem. 2019. PMID: 31570632. doi:10.1373/clinchem.2019.306365
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。